Biotherapy of chronic myelogenous leukemia W. E. AulitzkyC. PeschelC. Huber Review Article Pages: 113 - 120
The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML — A comparative morphometric study on sequential trephine biopsies J. ThieleH. M. KvasnickaR. Fischer Original Article Pages: 121 - 128
P53 Tumor suppressor gene in chronic myelogenous leukemia: A sequential study A. RoviraA. Urbano-IspizuaC. Rozman Original Article Pages: 129 - 133
Pulmonary fungal infections in patients with hematological malignancies — Diagnostic approaches M. von EiffM. ZühlsdorfJ. van de Loo Original Article Pages: 135 - 141
Risks of rhG-CSF treatment in drug-induced agranulocytosis H. DemuynckP. ZachéeM. A. Boogaerts Original Article Pages: 143 - 147
Presenting signs and symptoms in multiple myeloma: High percentages of stage III among patients without apparent myeloma-associated symptoms F. OngJ. HermansJ. C. Kluin-Nelemans Original Article Pages: 149 - 152
Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia E. WeidmannJ. BriegerP. S. Mitrou Original Article Pages: 153 - 158
Molecular identification of hereditary persistence of fetal hemoglobin type 2 (HPFH type 2) in patients from Brazil M. S. GonçalvesS. FahelF. F. Costa Original Article Pages: 159 - 161
Lineage-unrestricted hematologic response to granulocyte colony-stimulating factor in a patient with refractory anemia with excess blasts N. YokoseK. OgataT. Nomura Case Report Pages: 163 - 167
Erroneously low APC ratio in patients with lupus anticoagulant M. E. GschwandtnerK. LechnerI. Pabinger Letter to the Editors Pages: 169 - 170